Search results
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 2 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 4 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 2 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
Trials to watch: Phase III BCG naïve non-muscle invasive bladder cancer
Clinical Trials Arena via Yahoo Finance· 1 day ago(SWOG) is investigating different strains of BCG in a Phase III trial (NCT03091660). The trial is...
US FDA approves Merck's pneumococcal vaccine for adults By Reuters
Investing.com· 4 days agoMerck's vaccine, branded Capvaxive, helped produce an immune response against all 21 serotypes, or...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
CNBC· 4 days agoThe Food and Drug Administration on Monday approved Merck's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and ...
Gateway - Quartz
Quartz· 3 days agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19 vaccines off ...
US FDA Approves Merck's Pneumococcal Vaccine for Adults
US News & World Report· 4 days agoMerck's vaccine, branded Capvaxive, helped produce an immune response against all 21 serotypes, or variations of the bacteria, that the shot targeted in a variety of adult ...